The Phaserl


FDA Approves Phase 3 Clinical Trial of Ecstasy for PTSD Sufferers

by Julie Fidler, Natural Society:

The FDA gave permission on November 29 for large-scale, Phase 3 clinical trials of Ecstasy for people suffering with post-traumatic stress disorder, or PTSD. Many people swear the currently-illicit street drug has saved their lives, and if the trial is successful, it would establish Ecstasy as a legitimate prescription drug. [1]

Preliminary trials of Ecstasy, also called MDMA, for PTSD have been successful, but a large-scale trial is necessary before the FDA can approve it. [2]

Multidisciplinary Association for Psychedelic Studies (MAPS), the organization funding the trial involving 230 participants, has in the past studied Ecstasy’s effects on veterans, sexual assault victims, police, and firefighters suffering from PTSD. Said researcher Michael Mithoefer:

Read More @

Help us spread the ANTIDOTE to corporate propaganda.

Please follow SGT Report on Twitter & help share the message.

1 comment to FDA Approves Phase 3 Clinical Trial of Ecstasy for PTSD Sufferers

  • rich

    Emma’s Story: with science on her side, one little girl finds hope

    Published on Nov 22, 2016
    “Without basic research, there would be no hope…”

    Emma’s prognosis was grim. Spinal Muscular Atrophy (SMA) was crippling her and it seemed that nothing could stop it. That’s now changing thanks to an amazing opportunity — one made possible by the tireless work of Dr Adrian Krainer and his lab at Cold Spring Harbor Laboratory

    The longer the FDA waits to approve, the more kids/patients suffer.

Leave a Reply

You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>